Your email has been successfully added to our mailing list.

×
0 -0.0212765957446808 -0.00265957446808514 -0.00851063829787235 0.0246010638297872 0.0436170212765958 0.0154255319148936 0.0343085106382978
Stock impact report

ObsEva up 34% premarket on successful mid-stage linzagolix study [Seeking Alpha]

ObsEva SA - Common Shares (OBSV) 
Last obseva sa - common shares earnings: 3/5 01:00 am Check Earnings Report
Company Research Source: Seeking Alpha
ObsEva up 34% premarket on successful mid-stage linzagolix studyThinly traded ObsEva SA (NASDAQ:OBSV) is up34% premarket on light volume in response to itsannouncement of positive results from a Phase 2b clinical trial, EDELWEISS, evaluating linzagolix in endometriosis-associated pain.The study met the primary endpoint of a statistically significant proportion of responders (56.3 - 61.5% depending on the dose) compared to placebo (34.5%).Key secondary endpoints were also met.Phase 3 studies are next up.See all stocks on the move »Now read:Eidos Therapeutics Readies $100 Million U.S. IPO » Show less Read more
Impact Snapshot
Event Time:
OBSV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for OBSV alerts
Opt-in for
OBSV alerts

from News Quantified
Opt-in for
OBSV alerts

from News Quantified